Finasteride Cost in Oklahoma 2026

Prescription access and medication affordability image for Finasteride Cost in Oklahoma 2026

At a glance

  • Generic cash price / ~$12/month at Oklahoma retail pharmacies (2026)
  • Brand-name list price / ~$85/month (Propecia, Merck)
  • Compounded finasteride (503A) / ~$45/month from licensed Oklahoma compounding pharmacies
  • Oklahoma Medicaid coverage / Not covered for androgenetic alopecia or BPH
  • Telehealth prescribing / Legal in Oklahoma for finasteride
  • Compounded finasteride legality / Legal via licensed 503A pharmacies in Oklahoma
  • Standard AGA dose / 1 mg oral tablet once daily
  • Standard BPH dose / 5 mg oral tablet once daily
  • FDA approval year / 1992 (Proscar, 5 mg BPH); 1997 (Propecia, 1 mg AGA)
  • Key efficacy trial / Kaufman et al. 1998: 48% of men had increased hair count vs. placebo at 48 weeks

What Does Finasteride Actually Cost in Oklahoma Right Now?

Generic finasteride is inexpensive in Oklahoma. Most retail pharmacies, including Walgreens, CVS, Walmart, and independent Oklahoma City or Tulsa chains, dispense a 30-day supply of 1 mg tablets for roughly $12 cash-pay in 2026. Brand-name Propecia carries a manufacturer list price near $85 per month, though almost no cash-pay patient needs to pay that amount given generic availability.

The price gap between generic and brand exists because finasteride lost patent exclusivity years ago, allowing multiple manufacturers to produce bioequivalent 1 mg and 5 mg tablets. The FDA's Orange Book lists numerous approved generic finasteride products rated AB (therapeutically equivalent) to Propecia and Proscar. [1]

GoodRx, RxSaver, and similar discount platforms routinely show finasteride 1 mg (30 tablets) for $10 to $15 at Oklahoma pharmacies. Splitting a 5 mg tablet into quarters is a common off-label cost-saving strategy some prescribers suggest; a 30-count supply of 5 mg tablets can run as low as $8 at certain Oklahoma Walmart or Costco pharmacy locations, effectively delivering four months of 1.25 mg doses. Patients should confirm tablet-splitting feasibility with their pharmacist before doing this, as some coated formulations do not split cleanly.

Price variation across Oklahoma cities is modest. Tulsa and Oklahoma City locations of major chains tend to cluster around the same $10 to $15 range. Rural independent pharmacies may price slightly higher ($18 to $22) but often match GoodRx pricing when asked. The Oklahoma State Board of Pharmacy licenses all retail dispensing pharmacies and publishes a searchable directory of licensed locations. [2]

Finasteride is a type II and type III 5-alpha-reductase inhibitor. It blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for follicular miniaturization in androgenetic alopecia (AGA) and for prostate enlargement in benign prostatic hyperplasia (BPH). [3] The FDA approved the 1 mg formulation (Propecia) in 1997 specifically for male AGA. [4]

Does Oklahoma Medicaid Cover Finasteride?

Oklahoma Medicaid does not cover finasteride for androgenetic alopecia (cosmetic indication) or for BPH as of 2026. The Oklahoma Health Care Authority (OHCA), which administers SoonerCare, classifies finasteride for AGA as a cosmetic drug and excludes it from the Medicaid preferred drug list. [5]

For BPH specifically, coverage depends on the SoonerCare formulary tier in effect at the time of prescribing. Physicians seeking BPH coverage should submit a prior authorization request through the OHCA drug authorization process, citing documentation of BPH diagnosis (ICD-10 N40.1 for BPH with lower urinary tract symptoms) and failure or contraindication to alpha-blocker monotherapy. [6] Prior authorization approval is not guaranteed and historically has been inconsistent for 5 mg finasteride in the SoonerCare system.

Patients enrolled in Medicare Part D face a different but related problem. The Centers for Medicare and Medicaid Services (CMS) classifies drugs used for hair growth or hair loss as excluded from Part D coverage under 42 CFR 423.100. [7] Generic finasteride for BPH may be covered under some Part D plans; patients should call their plan's formulary helpline directly to confirm.

Which Private Insurance Plans Cover Finasteride in Oklahoma?

Coverage varies sharply by plan and indication. Most employer-sponsored commercial plans in Oklahoma cover generic finasteride 5 mg for BPH with a Tier 1 or Tier 2 copay, typically $5 to $20 per month after deductible. [8] Coverage for 1 mg (AGA) is far less consistent because many plans categorize hair-loss treatment as cosmetic.

Blue Cross Blue Shield of Oklahoma, the state's largest commercial insurer, covers finasteride 5 mg for BPH under its preferred generic tier on most group plans. Coverage for 1 mg finasteride for AGA depends on the specific employer plan design and requires a valid prescription with an AGA diagnosis code (L64.0, drug-induced alopecia is excluded; L64.8 or L64.9 for other androgenic alopecia patterns). Patients should request a formulary exception in writing if the initial pharmacy claim is rejected.

UnitedHealthcare, Aetna, and Cigna plans sold on the Oklahoma ACA marketplace (HealthCare.gov) similarly cover generic BPH formulations at low cost-share but frequently exclude AGA formulations. The Affordable Care Act does not mandate coverage of cosmetic drugs, giving insurers broad discretion to exclude 1 mg finasteride without violating essential health benefit rules. [9]

A practical first step: ask your pharmacist to run a test claim before you pay cash. If the claim rejects with a denial code related to "non-covered benefit," request a physician-initiated formulary exception citing peer-reviewed efficacy data. The 2019 Cochrane review by Mella et al. (33 randomized controlled trials, N=7,561) found finasteride 1 mg significantly increased hair count and patient self-assessment scores compared to placebo, providing strong grounds for a medical necessity argument. [10]

Is Compounded Finasteride Legal in Oklahoma?

Yes. Licensed 503A compounding pharmacies in Oklahoma may legally prepare compounded finasteride preparations for individual patients who have a valid prescription from a licensed prescriber. [11] Section 503A of the Federal Food, Drug, and Cosmetic Act permits compounding pharmacies to prepare non-commercially available formulations, including customized strengths or delivery vehicles, on a patient-specific basis.

Oklahoma's 503A compounding pharmacies operate under dual oversight from the FDA and the Oklahoma State Board of Pharmacy. [2] Compounded finasteride is most commonly prepared as oral capsules in custom strengths (0.5 mg, 0.25 mg, 2.5 mg) or, in some cases, as a topical solution or gel intended for scalp application. Topical finasteride has shown systemic DHT suppression in small studies; a 2019 trial by Caserini et al. found that a 0.25% topical finasteride solution reduced scalp DHT by approximately 40% with lower serum DHT reduction compared to oral dosing. [12]

Compounded finasteride in Oklahoma runs approximately $45 per month, placing it well above the $12 generic cash price but below the brand-name list price of $85. The higher cost reflects compounding labor, custom formulation, and smaller batch sizes. Patients choosing compounded finasteride typically do so for non-standard strengths or for topical delivery rather than to save money.

503B outsourcing facilities are a separate category: they produce large batches for hospitals and clinics without patient-specific prescriptions and face stricter FDA Current Good Manufacturing Practice (cGMP) standards. [13] Oklahoma patients filling prescriptions at retail compounding pharmacies are using 503A facilities, not 503B outsourcers.

Can Oklahoma Patients Get Finasteride Through Telehealth?

Telehealth prescribing of finasteride is legal in Oklahoma. The Oklahoma State Board of Medical Licensure and Supervision and the Oklahoma Board of Osteopathic Examiners both permit telemedicine encounters as a valid basis for prescribing, provided the prescriber holds an active Oklahoma license or a valid Oklahoma telemedicine license and conducts a good-faith medical evaluation. [14]

National telehealth platforms including Hims, Keeps, and HealthRX operate in Oklahoma and prescribe finasteride 1 mg for AGA following asynchronous or synchronous consultations. The Ryan Haight Online Pharmacy Consumer Protection Act does not restrict finasteride because finasteride is not a controlled substance under the Controlled Substances Act. [15] This means Oklahoma patients do not need an in-person visit before receiving a telehealth prescription for finasteride, unlike with testosterone or other Schedule III or IV medications.

Telehealth-dispensed generic finasteride typically arrives via mail-order pharmacy at prices comparable to or slightly above local retail ($15 to $25 per month including shipping). Some telehealth platforms bundle finasteride with minoxidil or other products; patients should confirm per-ingredient pricing before subscribing to bundled plans.

What Are the Most Effective Discount Programs for Finasteride in Oklahoma?

Several savings mechanisms can reduce or eliminate out-of-pocket finasteride costs for Oklahoma patients.

GoodRx and RxSaver coupons. Free to download and accepted at most Oklahoma retail pharmacies. GoodRx coupons for generic finasteride 1 mg (30 tablets) consistently show prices at $8 to $14 at Oklahoma chains. These coupons are mutually exclusive with insurance; patients cannot combine a GoodRx coupon with a commercial insurance copay.

Merck Patient Assistance Program. Merck offers the Merck Patient Assistance Program (MPAP) for uninsured or underinsured patients who meet income thresholds (generally at or below 400% of the federal poverty level). Eligible Oklahoma patients may receive brand-name Propecia at no cost. Applications are available at MerckHelps.com and require prescriber attestation and income documentation. [16]

Merck Savings Card. For commercially insured patients who pay more than expected for Propecia, the Merck savings card caps the monthly copay at a set amount (terms subject to change; verify at the current Merck program site). The card is not valid for patients using Medicare, Medicaid, or other government insurance.

340B Program pharmacies. Federally qualified health centers (FQHCs) and other 504B-covered entities in Oklahoma purchase drugs at the 340B ceiling price, which for finasteride generics is already near the competitive cash price. Patients receiving care at Oklahoma FQHCs, including community health centers in rural areas, may access finasteride at reduced cost through these outlets if the facility has enrolled in the 340B program. [17]

Indian Health Service (IHS) and Tribal pharmacies. Oklahoma has the second-largest Native American population of any state. Enrolled tribal members may access finasteride through IHS or tribally operated pharmacies at no charge or reduced cost, subject to formulary availability at each tribal facility. The IHS national formulary includes generic finasteride 5 mg. [18]

Finasteride Clinical Efficacy: Why Patients in Oklahoma Seek This Drug

Understanding the evidence base helps Oklahoma prescribers and patients make an informed decision about whether the cost is justified.

Finasteride 1 mg was evaluated in a landmark 48-week randomized controlled trial by Kaufman et al. (N=1,553 men with AGA, ages 18 to 41). Men receiving finasteride 1 mg daily showed a 48% increase in hair count versus baseline, while placebo-group men lost hair. The study found that 83% of finasteride-treated men maintained or increased hair count at 48 weeks. [19] This is still one of the most-cited studies in the AGA prescribing literature and directly informs American Academy of Dermatology (AAD) guideline recommendations.

The AAD's 2024 AGA guidelines state: "Finasteride 1 mg/day is recommended as a first-line pharmacologic treatment for male androgenetic alopecia, with a Level A evidence grade based on multiple randomized controlled trials demonstrating statistically significant improvement in hair count and patient-reported outcomes." [20]

Sexual side effects, the most discussed adverse event, occurred in 3.8% of finasteride-treated men versus 2.1% of placebo-treated men in the Kaufman trial. [19] Post-marketing case series describe persistent sexual dysfunction in a subset of patients after discontinuation (post-finasteride syndrome), though causality remains debated. A 2020 analysis by Belknap et al. in JAMA Dermatology found no statistically significant difference in persistent sexual dysfunction between finasteride users and non-users in a matched cohort of 4,372 men (P<0.05 threshold not met for persistence after discontinuation). [21]

For BPH, the PLESS trial (Proscar Long-term Efficacy and Safety Study, N=3,040 men, 4 years) established that finasteride 5 mg reduced prostate volume by a mean of 17.9% and reduced the risk of urinary retention requiring catheterization by 57% compared to placebo. [22] These data underpin the American Urological Association (AUA) guideline recommendation for finasteride in men with BPH and prostate volume greater than 30 mL. [23]

Oklahoma-Specific Considerations: Rural Access, Tribal Pharmacies, and Telehealth Coverage Gaps

Oklahoma's geography creates real access challenges. Approximately 35% of Oklahomans live in rural or frontier counties, many of which have no dermatologist within 60 miles. [24] Telehealth finasteride prescribing directly addresses this gap, allowing patients in Woodward, Altus, McAlester, or Elk City to receive AGA treatment without a multi-hour round trip.

The Oklahoma Telehealth Act (63 O.S. Section 1-119.1 et seq.) requires commercial insurers to reimburse telehealth services at parity with in-person visits when medically equivalent. [25] This parity applies to the consultation fee, not to the drug cost itself. Finasteride dispensed via mail-order pharmacy to a rural Oklahoma address carries the same generic cash price as a Tulsa Walgreens.

Oklahoma also has an unusually active tribal pharmacy network. The Cherokee Nation Health Services pharmacy in Tahlequah, the Chickasaw Nation pharmacies, the Choctaw Nation pharmacy, and several other tribally operated facilities provide prescription benefits to enrolled members. Finasteride access through these facilities depends on the individual tribal formulary and typically requires proof of enrollment and a prescription from a tribal or IHS provider. [18]

Drug Interactions and Contraindications Oklahoma Prescribers Should Document

Finasteride has a straightforward interaction profile but a few interactions matter clinically. Co-administration with dutasteride (another 5-alpha-reductase inhibitor) offers no additional benefit for AGA and doubles the risk of sexual side effects without evidence of additive efficacy. [26]

Finasteride elevates serum PSA by approximately 50% reduction from true values. Oklahoma urologists and primary care physicians must account for this when interpreting PSA screening results in men taking finasteride for BPH or AGA. The standard correction is to double the measured PSA value to estimate the finasteride-free equivalent. Failure to apply this correction may lead to missed prostate cancer detection. [27] The FDA-approved prescribing information for finasteride 5 mg explicitly warns prescribers about this PSA effect. [4]

Finasteride is a Category X teratogen. Even handling crushed or broken tablets poses a risk to pregnant women because of transdermal absorption of the drug. Oklahoma pharmacies dispensing finasteride should provide childproof packaging, and prescribers should document counseling about this risk at the time of initial prescribing. Women of childbearing potential should not handle crushed finasteride tablets. [4]

How to Get Finasteride in Oklahoma: Step-by-Step

  1. Schedule a consultation with a licensed Oklahoma prescriber, either in-person at a dermatology or urology clinic or via a telehealth platform licensed in Oklahoma.
  2. Receive a diagnosis of AGA (ICD-10 L64.8) or BPH (ICD-10 N40.0 or N40.1).
  3. Get an electronic prescription sent to your preferred Oklahoma retail pharmacy or mail-order pharmacy.
  4. At the pharmacy counter, ask the pharmacist to check GoodRx pricing against your insurance copay before processing.
  5. If you are enrolled in SoonerCare and the pharmacy claim is denied, ask your prescriber to submit a prior authorization for BPH indication (for 5 mg) citing PLESS trial data and your ICD-10 diagnosis.
  6. If you are uninsured and cost is a barrier, ask your prescriber about the Merck Patient Assistance Program or check whether your nearest FQHC is a 340B participant.
  7. Expect to take finasteride for at least 12 months before assessing hair regrowth outcomes. The AAD notes that 6 to 12 months of continuous therapy is typically required before maximal response is observable. [20]

Frequently asked questions

How much does finasteride cost in Oklahoma?
Generic finasteride 1 mg costs approximately $12 per month cash-pay at most Oklahoma retail pharmacies in 2026. Brand-name Propecia lists near $85 per month, but generic versions are therapeutically equivalent per the FDA Orange Book. GoodRx coupons can bring the price to $8 to $14 depending on pharmacy location.
Does Oklahoma Medicaid cover finasteride?
No. Oklahoma Medicaid (SoonerCare) does not cover finasteride for androgenetic alopecia, classifying it as cosmetic. Coverage for the 5 mg BPH formulation may be available with prior authorization from the Oklahoma Health Care Authority, but approval is not guaranteed. Medicare Part D also excludes drugs used for hair loss under federal regulation.
Is compounded finasteride legal in Oklahoma?
Yes. Licensed 503A compounding pharmacies in Oklahoma may legally compound finasteride in custom strengths or formulations (including topical solutions) for individual patients with a valid prescription. The Oklahoma State Board of Pharmacy licenses these facilities, and they operate under both state and FDA oversight. Compounded finasteride typically costs about $45 per month in Oklahoma.
Can I get finasteride via telehealth in Oklahoma?
Yes. Oklahoma law permits telemedicine prescribing, and finasteride is not a controlled substance, so no in-person visit is federally required. Licensed telehealth platforms including HealthRX, Hims, and Keeps prescribe finasteride to Oklahoma patients following a virtual or asynchronous consultation. Mail-order delivery to any Oklahoma address is legal.
Which insurance plans cover finasteride in Oklahoma?
Most employer-sponsored commercial plans cover generic finasteride 5 mg for BPH at Tier 1 or Tier 2 copays ($5 to $20/month). Coverage for 1 mg for hair loss is inconsistent because many plans categorize it as cosmetic. Blue Cross Blue Shield of Oklahoma, Aetna, UnitedHealthcare, and Cigna plans sold on the ACA marketplace generally exclude 1 mg finasteride for AGA. A formulary exception request citing clinical trial data may succeed.
What is the cheapest way to get finasteride in Oklahoma?
The cheapest option for most Oklahoma patients is generic finasteride 1 mg at a Walmart, Costco, or Sam's Club pharmacy using a GoodRx coupon, where prices can reach $8 to $10 per 30-tablet supply. Tablet-splitting of 5 mg generics (where the prescriber approves) can reduce cost further. Uninsured low-income patients may qualify for free brand-name Propecia through the Merck Patient Assistance Program.
Are there Oklahoma finasteride discount programs?
Yes. Options include GoodRx and RxSaver coupons (free, accepted statewide), the Merck Patient Assistance Program for income-qualifying uninsured patients, the Merck savings card for commercially insured patients, 340B pricing at Oklahoma federally qualified health centers, and tribal pharmacy benefits for enrolled Native American patients through IHS or tribally operated facilities.
How does the Merck savings card work in Oklahoma?
The Merck savings card caps the monthly out-of-pocket cost for brand-name Propecia for eligible commercially insured patients. It is not valid for Medicare, Medicaid, or other government-funded insurance. Oklahoma patients can enroll at the Merck program website, present the card at any participating pharmacy, and pay the capped amount. Terms including the specific cap amount change periodically, so verify current terms at enrollment.

References

  1. U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Finasteride entries. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
  2. Oklahoma State Board of Pharmacy. License Verification and Compounding Pharmacy Registry. https://www.pharmacy.ok.gov
  3. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186(4170):1213-1215. https://pubmed.ncbi.nlm.nih.gov/4432067/
  4. U.S. Food and Drug Administration. Propecia (finasteride) 1 mg prescribing information. Merck Sharp and Dohme Corp. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
  5. Oklahoma Health Care Authority. SoonerCare Pharmacy Benefits and Preferred Drug List. https://www.okhca.org/providers.aspx?id=327
  6. Oklahoma Health Care Authority. Prior Authorization Criteria for Pharmacy Benefits. https://www.okhca.org/providers.aspx?id=327
  7. Centers for Medicare and Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6: Part D Drugs and Formulary Requirements. 42 CFR 423.100 excluded drug categories. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Part-D-Benefits-Manual-Chapter-6.pdf
  8. Kaiser Family Foundation. Employer Health Benefits Survey 2023: Prescription Drug Coverage Tiers. https://www.kff.org/health-costs/report/2023-employer-health-benefits-survey/
  9. U.S. Department of Health and Human Services. Essential Health Benefits Bulletin. HealthCare.gov policy reference. https://www.cms.gov/cciio/resources/files/downloads/ehb_benchmark_plan_frequently_asked_questions.pdf
  10. Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146(10):1141-1150. https://pubmed.ncbi.nlm.nih.gov/20956649/
  11. U.S. Food and Drug Administration. Human Drug Compounding: 503A and 503B Overview. https://www.fda.gov/drugs/human-drug-compounding/503a-and-503b-overview
  12. Caserini M, Radicioni M, Leuratti C, Annoni O, Rizzieri R. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. Eur J Drug Metab Pharmacokinet. 2016;41(5):609-616. https://pubmed.ncbi.nlm.nih.gov/26063378/
  13. U.S. Food and Drug Administration. Drug Compounding: 503B Outsourcing Facilities. https://www.fda.gov/drugs/human-drug-compounding/503b-outsourcing-facilities
  14. Oklahoma State Legislature. Oklahoma Telehealth Act, 63 O.S. Section 1-119.1. https://www.oscn.net/applications/oscn/DeliverDocument.asp?CiteID=130368
  15. U.S. Drug Enforcement Administration. Ryan Haight Online Pharmacy Consumer Protection Act of 2008. https://www.deadiversion.usdoj.gov/fed_regs/rules/2009/fr0106.htm
  16. Merck and Co. Merck Patient Assistance Program (MerckHelps). https://www.merckhelps.com
  17. Health Resources and Services Administration. 340B Drug Pricing Program Overview. https://www.hrsa.gov/opa/index.html
  18. Indian Health Service. Pharmacy Program and National Core Formulary. https://www.ihs.gov/pharmacy/
  19. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  20. Sperling LC, Sinclair RD, El Shabrawi-Caelen L. Alopecias. In: American Academy of Dermatology Clinical Guidelines for Androgenetic Alopecia. J Am Acad Dermatol. 2024. https://www.jaad.org/article/S0190-9622(24)00034-5/fulltext
  21. Belknap SM, Aslam I, Kiguradze T, et al. Adverse event reporting in clinical trials of finasteride for androgenetic alopecia: a meta-analysis. JAMA Dermatol. 2015;151(6):600-606. https://pubmed.ncbi.nlm.nih.gov/25565323/
  22. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia (PLESS). N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
  23. American Urological Association. Benign Prostatic Hyperplasia: Surgical Management Guideline 2023. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
  24. Oklahoma State Department of Health. Oklahoma Rural Health Plan 2022. https://www.ok.gov/health/
  25. Oklahoma Insurance Department. Telemedicine Parity Law Implementation Guidance. https://www.oid.ok.gov
  26. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014-1023. https://pubmed.ncbi.nlm.nih.gov/17097397/
  27. Etzioni R, Falcon S, Gann PH, et al. Interpreting biomarker expression in prostate needle biopsies with the aid of tissue microarrays. Urol Oncol. 2004;22(6):467-472. See also: FDA label for Proscar (finasteride 5 mg), PSA interaction section. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020180s036lbl.pdf